1994
DOI: 10.1016/1043-4666(94)90059-0
|View full text |Cite
|
Sign up to set email alerts
|

Neurochemical basis of interleukin 2-modified discrimination behaviour

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…IL‐2 potentiates novelty‐induced and the DA uptake inhibitor GBR 12909‐induced exploratory activity, suggesting that this cytokine has modulatory effects on the mesocorticolimbic DA system 32. In fact, IL‐2 potentiates discriminative stimulus effects of amphetamine and ethylketocyclazocine 33…”
Section: Interleukinsmentioning
confidence: 99%
See 1 more Smart Citation
“…IL‐2 potentiates novelty‐induced and the DA uptake inhibitor GBR 12909‐induced exploratory activity, suggesting that this cytokine has modulatory effects on the mesocorticolimbic DA system 32. In fact, IL‐2 potentiates discriminative stimulus effects of amphetamine and ethylketocyclazocine 33…”
Section: Interleukinsmentioning
confidence: 99%
“…32 In fact, IL-2 potentiates discriminative stimulus effects of amphetamine and ethylketocyclazocine. 33 Repeated IL-6 treatment increases sensitivity to the locomotor-stimulating effects of amphetamine. 34 Conversely, methamphetamine-induced DA and serotonin neurotoxicity were attenuated in the IL-6 knockout mice, although there was no difference in body temperature or methamphetamine levels between wild-type and the mutant animals.…”
Section: Interleukinsmentioning
confidence: 99%
“…administration of IL-6 (100). Moreover, IL-2 and interferon (IFN)-α potentiated the response induced by a psychostimulant drug in a protocol of drug discrimination behavioural effect using d -amphetamine (101,102). In contrast, TNF-α might play a different role in addiction.…”
Section: Neuroinflammation and Addiction: Role Of (Endo)cannabinoidsmentioning
confidence: 99%
“…IL-2 potentiates the DA uptake inhibitor GBR 12909induced exploratory activity (Vanoxerine (GBR-12909) is a piperazine by-product which is a potent and selective dopamine reuptake inhibitor), suggesting that this cytokine has modulatory effects on the mesocorticolimbic DA system [30]. IL-2 potentiates discriminative stimulus effects of amphetamine and ethylketocyclazocine [31].…”
Section: Introductionmentioning
confidence: 99%